1. Introduction {#sec1}
===============

PTB is a prevalent and economically important disease that affects cattle and thus impacts on the cattle industry. It is caused by MAP.

Clinical PTB is characterized by chronic granulomatous enteritis with clinical signs of diarrhea, weight loss, decreased milk production, and mortality. However, most infected cattle show no clinical signs during the prolonged incubation stage of infection \[[@B1]\].

On the other hand, a number of theories have proposed that the principal infective agent of Crohn\'s disease, a chronic enteropathy in humans, is MAP \[[@B2]--[@B4]\]. The economic impact and possible link to Crohn\'s disease highlights the importance of the development of control programs at the herd level. To this end, it is necessary to improve the diagnostic methods of PTB.

Cattle are most often infected as young calves, before 6 month of age, but some studies have shown that infection may also occur in adult cattle. Fecal shedding of MAP generally starts after 2 years, and clinical symptoms appear after an incubation period of 2--10 years. In addition, the elimination of the agent through the stool is very variable \[[@B5]\].

Cell-mediated immune response wanes with progression of the disease and when this occurs, a humoral immune response becomes measurable. It has been shown that cattle are more likely to have a combined antibody and cellular response rather than a switch from cellular to antibody response \[[@B6]--[@B8]\]. Among tests to detect serum antibody to MAP, ELISAs are the most widely used. Several commercial ELISA kits for bovine PTB are currently available, and multiple studies have compared their accuracy \[[@B9], [@B10]\]. Comparative studies of ELISAs with different antigens have shown discrepancies in the ability of these tests to identify all infected animals \[[@B11]\]. Some authors have suggested that this may be due to the lack of representation of the entire range of immunodominant antigens for MAP in a given ELISA test \[[@B12]\]. Then, one of the crucial components of this test is the antigen used for the preparation of the ELISA test. The antigen most widely used for the serological diagnosis of PTB is PPA-3, which is the *M. avium* strain 18 protoplasmic antigen. Currently, antigen-based tests to detect MAP with a mixture of proteins include whole-cell sonicated extract, parcel purified antigen, and protoplasmic antigens. These antigens show variability in potency and cross-reaction. This diagnostic method has drawbacks due to the cross-reaction with animals sensitized with this mycobacterium or other pathogens antigenically related to MAP \[[@B11]\]. Since the sequencing and analysis of the entire MAP genome was obtained \[[@B13]\], several specific proteins have been detected in the genome of MAP and the immunoreactivity of these proteins investigated \[[@B14]\]. Bannantine et al. \[[@B15]\] developed a spot protein array for initial antigen screening. Available diagnostic MAP antigens are reviewed in Mikkelsen et al. \[[@B16]\]. However, individual antigens are able to identify only a subset of PTB-infected animals. Then, a mix of antigens could be a good candidate for serological diagnosis.

In the present work, MAP antigens were obtained after fractionating proteins from the whole cell or membrane or secreted fraction, resolved with two-dimensional gels, printed in line onto nitrocellulose membranes, and analyzed with sera from animals with PTB.

MAP proteins recognized specifically by sera from PTB-infected animals were used to develop a cocktail of selected antigens to be evaluated by ELISA.

2. Material and Methods {#sec2}
=======================

2.1. Animals {#sec2.1}
------------

Sera from a total of 43 animals from different groups (a) cattle coming from PTB-free herds and with MAP negative fecal cultures (negative control animals) (*n* = 10), (b) cattle naturally infected, with MAP-positive fecal cultures or ELISA-positive tests (*n* = 25), and (c) animals experimentally infected with *M. bovis* with lesions (*n* = 8) were used to evaluate the 54 recombinant proteins of MAP.

The final screening using a cocktail of seven selected antigens was carried out with sera from 68 cattle: 25 cows with MAP positive fecal culture or ELISA-positive tests, 26 cows from negative herds with no suspected cases of PTB and negative tests (fecal cultures, serology and INF-g), and 17 from animals experimentally infected with *M. bovis* and with lesion at the time of necropsy.

2.2. Selection of Antigens {#sec2.2}
--------------------------

With the aim of identifing and characterizing immunoreactive proteins for their possible use in diagnosis, we extracted proteins of MAP by treatment of cells with sodium dodecyl sulfate at 50°C \[[@B17]\]. The proteins were resolved by one- or two-dimensional SDS-PAGE, carried out in duplicate. Both duplicates were stained with colloidal Coomassie blue and the other was transferred to a nitrocellulose membrane (Amersham Hybond-ECL, GE Healthcare Life Sciences, Buckinghamshire, UK) to perform a Western blot with a PTB-positive bovine serum sample. Six proteins were immunoreactive with sera from animals with PTB and as nonimmunoreactive with sera from animals infected with *M. avium*. These proteins were cut from the gel and identified by MALDI TOF. This study identified these proteins as encoded by MAP 1962 (Glutamine synthetase), MAP 4143 (Elongation factor tu), MAP 0187c (SodA), MAP 3194, MAP 3205, and MAP 3206, as potential diagnostic antigens.

The other 48 proteins here evaluated were from CIDC-Lelystad,Central Institute for Animal Disease Control Department Bacteriology, and TSEs, Lelystad, the Netherlands.

2.3. Recombinant Antigens {#sec2.3}
-------------------------

The 54 proteins were produced as recombinant. Briefly, they were cloned and purified essentially as described previously \[[@B18]\], where all proteins were PCR-cloned using 5′- and 3′-primers amplifying DNA fragments encoding the mature protein except for secreted proteins, which were cloned without the signal peptide. The DNA fragments were cloned into expression vectors. The antigens were cloned into the pET33b (Novagen Inc.,Madison, WI,USA) and pRSET (Invitrogen Corp., Carlsbad, CA, USA) vectors, and expression was induced by the production of T7 RNA polymerase in BL21 (DE3) *E. coli*. These cells also produce T7 lysozyme to reduce the basal expression of the target genes. The secreted antigens described in Willemsem et al. \[[@B18]\] (MAP 2609, MAP 2942c and MAP 0210c) were cloned in pQE80 (Qiagen, Germantown, MD, USA). Antigens were purified using their histidine-tagged N-terminal region and Nickel-affinity columns, (1 mL HisTrap HP columns) (GE Healthcare Life Sciences, UK). Before that, solubilization of the recombinant antigen was established by a buffer containing 6 M Guanidine, 20 mM Tris (pH 8.0), 0.5 M NaCl, or 50 mM Imidazol, 0.25% CHAPS, 1 mM DTT, 0.5 mM PMSF, and 1% iso-propanol to solve proteins from inclusion bodies (Guanidine), reduce nonspecific binding (Imidazol), and decrease the amount of LPS (iso-propanol) or 8 M Urea. After affinity-purification, the antigens were dialyzed (10 kDa cut-off, except for Map 4000c, for which a 1 kDa cut-off was used) against a buffer containing 0 to 6 M Urea, 10 mM Tris (pH 8.0), 25% glycerol, 1 mM DTT, 0.5 mM PMSF, 1% iso-propanol or 0 to 7 M Urea, 10 mM Tris (pH 8.0), 10% glycerol, 1 mM DTT, 0.5 mM PMSF, and 1% iso-propanol. The urea concentration was the minimal concentration needed to keep the proteins solubilized and determined empirically.

The recombinant proteins were analyzed by Coomassie-stained SDS-PAGE to test purity.

2.4. Coomassie Blue Staining {#sec2.4}
----------------------------

A gel containing six of the recombinant purified proteins included in the cocktail is shown in [Figure 1](#fig1){ref-type="fig"}. The protein encoded by MAP 0209c (of 56.5 kDa) is shown on the first lane but is not visible because it is very close to the front of the run. The proteins were run in a 15% polyacrylamide gel and then incubated in a Coomassie blue solution 0.05% (Coomassie brilliant blue R250 0.05%, methanol 50%, acid acetic 10%) for 1.5 hours with agitation. The Coomassie blue solution was then removed and bleached with bleaching solution (methanol 50%, acetic acid 10%).

2.5. Evaluation of Humoral Response by a Line Print Immunoassay {#sec2.5}
---------------------------------------------------------------

The panel of 54 proteins was evaluated as follows: 20 *μ*L of each antigen was applied to a nitrocellulose membrane at a concentration of 100 *μ*g/mL, using a semiautomatic aerosolizer (Camag Scientific Inc., Wilmington, Delaware). The membranes were blocked with 50 mL of blocking solution (5% milk TBS) for 1 h. The membranes were then placed in a "miniblotter" (Isogen BioSolutions, the Netherlands). This allowed parallel analysis of 45 sera. We evaluated serum dilutions of 1 : 100. After 1 h incubation, the serum samples were aspirated and washed three times for 10 min with TBS 1x. The membrane was then incubated for 1 h with protein G conjugated to peroxidase (1 : 1500). The membrane was washed three times for 10 min with TBS 1X and revealed by chemiluminescence (Pierce ECL western blotting, Thermo Scientific, USA).

Line print immunoassay generated macroarrays of recombinant proteins which were evaluated with sera from animals with PTB. In order to identify potentially cross-reactive proteins, the macroarrays were also used to probe against sera from healthy animals and from animals experimentally infected with *M. bovis*. The macroarrays were subjected to densitometry analysis to provide quantification for reactivity at each spot, reported as spot intensities.

2.6. Bioinformatic and Statistical Análisis {#sec2.6}
-------------------------------------------

The panel of 54 recombinant proteins included in the present study was characterized *in silico*: molecular weight, location prediction, and homology with other mycobacterial proteins ([Table 1](#tab1){ref-type="table"}). PSORTb analysis was used to predict protein localization based on a number of factors including transmembrane helices, signal peptide, motif search, and similarity to proteins with known subcellular location. (<http://www.psort.org/psortb/>). According to PSORTb prediction, the set of recombinant proteins contains 28 cytoplasmic proteins, 7 cytoplasmic and membrane proteins, 6 extracellular proteins, and 13 proteins with uncertain localization ([Table 1](#tab1){ref-type="table"}).

BLAST similarity searches were performed locally on coding sequences by comparison with the GenBank nonredundant protein database ([Table 1](#tab1){ref-type="table"}).

2.7. Measurement of Spot Intensities {#sec2.7}
------------------------------------

Quantitative spot intensities were obtained by performing a densitometric scan of the membrane. For the analysis of the results, the intensities of the points were measured with the ImageQuant TL Array Version 7.0 Software, (GE Healthcare, Pittsburgh, PA).

This quantification software processes spot intensities on the array and determines the mean intensities of pixels within a spot as well as those of the background pixels around the spot. These local-background intensities are subtracted from the raw signals to obtain the local-background-corrected levels. The measured diameter that was selected for scans of different arrays was consistent for all the arrays in this study. Adjusted intensities were obtained following normalization of each spot. Five proteins (MAP 0038, MAP 1272, MAP 1693, MAP 0210c, and MAP 0209c) showed a stronger mean intensity with sera from MAP-infected animals than with sera from non-MAP-infected animals and were thus selected for a cocktail of antigens ([Table 2](#tab2){ref-type="table"}).

MAP 2020 and MAP 2513 were also selected because although they did not show a strong intensity with sera from MAP-infected animals, they recognized nine and six animals with PTB, respectively ([Table 3](#tab3){ref-type="table"}), and because these proteins had not been previously evaluated or reported in the literature.

2.8. ELISA {#sec2.8}
----------

The antigens used for the ELISA test were PPA-3 (Allied Monitor, Inc. USA) and a cocktail with the seven antigens selected (MAP 2513, MAP 1693, MAP 2020, MAP 0038, MAP 1272, MAP 0209c, and MAP 0210c). The cocktail was prepared with 30 *μ*g of each antigen for 1 mL of the mixture. The microtiter plates were coated at 4°C overnight with 100 *μ*L of 40 *μ*g/mL PPA-3 or 20 *μ*g/mL of the cocktail in carbonate buffer (pH: 9.6). Then, the plates were saturated with 100 *μ*L of PBS/0.5% w/v gelatin for 1 h at 37°C, then washed five times with PBS/0.1% Tween20 (PBS/T), and incubated for 1 h at 37°C with 100 *μ*L of 100-fold dilution of sera in PBS/T containing 0.5% (w/v) gelatin. The plates were then washed five times with PBS/T and incubated for 30 min at 37°C with 100 *μ*L of 1500-fold dilution of peroxidase-conjugated protein in PBS/T containing 0.5% (w/v) gelatin. Plates were washed five times with PBS/T, and 50 *μ*L of peroxidase substrate was added. Optical density (OD) was measured at 405 nm.

3. Results {#sec3}
==========

54 proteins were evaluated by Line print immunoassay with sera from healthy animals, animals with PTB, and animals experimentally infected with *M. bovis*. The stronger mean intensity values are listed in [Table 2](#tab2){ref-type="table"}. Serum samples with density values higher than the mean obtained with the control (PBS) were considered positive and the numbers of animals reactive with each protein are shown in [Table 3](#tab3){ref-type="table"}.

The antigens selected were those that showed stronger intensity with sera from MAP-infected animals than with sera from non-MAP-infected animals. These antigens were MAP 0038, MAP 0210c, MAP 1272, MAP 1693c, and MAP 0209, shown in bold in Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}. In addition, we selected two antigens, MAP 2020 and MAP 2513, because they recognized nine and six animals with PTB ([Table 3](#tab3){ref-type="table"}), respectively, and because they had not been previously evaluated or reported in the literature.

These results contributed to the development of an antigen mixture with seven antigens (MAP 0038, MAP 0210c, MAP 1272, MAP 1693c, MAP 2020, MAP 2513, and MAP 0209c).

The ORF of MAP 1272 codes for a protein that possesses an NLP/P60 domain of unknown function that is found in several lipoproteins. MAP 0210 codes for the P36/Erp protein of *M. bovis*, which has been studied in our laboratory \[[@B19]\]. PSORTB analysis software predicted that MAP 2513 is localized in the cytoplasm, MAP 0210c in the cytoplasm-membrane, and that MAP 1272 and MAP 0209c are extracellular. The remaining proteins were of unknown localization. All seven of these proteins have not been previously evaluated or reported in the literature, except for MAP 0210c, which has been studied by Willemsen et al. \[[@B18]\].

The cocktail of seven antigens was printed in the nitrocellulose membrane and evaluated by Line print immunoassay with sera from animals with PTB and healthy controls and animals experimentally infected with *M. bovis* ([Figure 2](#fig2){ref-type="fig"}). By line print immunoanalysis, 14 out of 25 of the sera from animals with PTB developed antibody response to the cocktail. This cocktail was not recognized with the sera from animals experimentally infected with *M. bovis* here evaluated and two serum samples from healthy animals gave a very weak signal ([Figure 2](#fig2){ref-type="fig"}).

In addition, ELISAs with PPA-3 and with the cocktail with seven antigens were evaluated with sera from animals with PTB (*n* = 25), healthy animals (*n* = 26), and animals experimentally infected with *M. bovis* (*n* = 17).

The ELISA-PPA-3 test recognized 16 out of the 25 animals with PTB (64%) but also 12 of the 17 animals experimentally infected with *M. bovis*, while the ELISA-cocktail detected 18 of 25 animals with PTB (72%) and only 3 of the 17 animals experimentally infected with *M. bovis* ([Figure 3](#fig3){ref-type="fig"}). Both ELISAs did not have a reaction with sera from non-infected controls; however, when using sera from *M. bovis*-infected, ELISA-PPA-3 test recognized (12/17) 70,5% of these animals and ELISA-cocktail (3/17) 17,6% of these animals.

This new ELISA for bovine PTB showed 72% of sensitivity and had higher specificity than the ELISA with PPA-3 as antigen, using animals experimentally infected with *M. bovis*.

4. Discussion {#sec4}
=============

The early and specific diagnosis of PTB is still a challenge. It has generally been believed that the early immune response to infection with MAP consisted primarily of a cellular immune response characterized by interferon gamma production, and this response would later be replaced by antibody production. However, some studies have shown that antibodies appear much earlier and therefore ELISA could be used as an early diagnostic tool \[[@B6]--[@B8]\]. Then it is necessary to characterize MAP antigens to increase the sensitivity and specificity of the ELISA test for PTB diagnosis. The MAP genome sequencing represented a significant advance and will most likely contribute with new tools for diagnosis. The evaluation of a specific panel of antigens such as that studied in the present work is the first step in the selection of candidates to be studied at different herds with PTB of our country. This is an important area, since novel antigens that could improve the diagnosis of MAP-infected cattle are needed.

The proteomic approach has been used to define specific antigens by 2D fraction of MAP proteins by several researchers \[[@B20]--[@B24]\]. Another approach to obtain specific antigens is to express recombinant proteins from cloned MAP-coding sequences and use them to construct a protein array \[[@B15]\]. Here we selected MAP proteins by 1D or 2D electrophoresis and developed macroarrays by line print of these proteins. These macroarrays were probed with sera from animals with PTB and healthy controls and animals experimentally infected with *M. bovis*.

After evaluation of 54 proteins of MAP with sera from PTB-infected, experimentally infected with *M. bovis* and healthy animals, we selected seven proteins, which were incorporated in an ELISA to develop an antigen-based diagnostic test (ELISA-cocktail). This new ELISA for bovine PTB showed 72% of sensitivity and had higher specificity than the ELISA with PPA-3 as antigen ([Figure 3](#fig3){ref-type="fig"}). This sensitivity was based on 25 animals from MAP fecal culture-positive or ELISA-positive cattle, because naturally infected cattle may represent various stages of MAP infection and serum samples only from culture-positive animals can express differentiated antigen patterns \[[@B25]\]. In addition, the use of only culture-positive animals to estimate the sensitivity of ELISA may increase the values of the test because most culture-positive animals are also ELISA-positive \[[@B11]\].

The results presented here suggest that several specific antigens can improve the detection of MAP infection. In fact, the profiles of antibody response varied considerably and then the antibody response to single antigens was not prominent, while simultaneous usage of several recombinant antigens is able to recognize the ongoing antibody response over time in the course of infection.

In summary, here we identified novel antigens of MAP by using multiple antigen print immunoassay. Based on this knowledge, we developed an antigen cocktail, which increased the correct diagnosis of MAP-infected animals in comparison with the results of ELISA-PPA-3. The study presents an antigen cocktail, which could be of diagnostic significance for further researches. However, the cocktail needs to be evaluated by larger sample sizes in order to estimate its sensitivity and specificity. In addition, the results here shown with the 54 proteins, indicated that other proteins not included were also good candidates. Then, new cocktails should be incorporated and evaluated to increase the sensitivity and specificity of the ELISA test for diagnosis of PTB.

This study was financially supported by FONARSEC and PICT of the Agencia Nacional de Promociòn Cientìfica y Tecnológica of Argentina.

![Recombinant proteins analyzed by coomassie-stained SDS-PAGE to test purity.](VMI2012-860362.001){#fig1}

![Evaluation of the cocktail by a Line print immunoassay. Result of the cocktail with seven antigens (MAP 0038, MAP 0210c, MAP 1272, MAP 1693, MAP 2020, MAP 0209c and MAP 2513) printed in a membrane of nitrocellulose and evaluated with the sera from healthy animals and animals infected with MAP and *M. bovis*.](VMI2012-860362.002){#fig2}

![Reactivity of bovine sera to the cocktail by ELISA. Comparison of the diagnostic performance of using PPA-3 (Allied monitor) and the antigen cocktail (MAP 0038, MAP 0210c, MAP 1272, MAP 1693, MAP 2020, MAP 0209c, and MAP 2513).](VMI2012-860362.003){#fig3}

###### 

Characterization *in silico* of a panel of 54 recombinant proteins, included in the present study.

  Antigen (ORF no.)   Predicted localization                                         Theoretical MW   Homology with other mycobacteria
  ------------------- -------------------------------------------------------------- ---------------- --------------------------------------------------------------------------------------------------------------------
  MAP 0011            Cytoplasmic                                                    19,196 kDa       Iron-regulated peptidyl-prolyl cis-trans isomerase A in *Mycobacterium tuberculosis* H37Rv
  MAP 0034            Cytoplasmic-Membrane                                           44 kDa           P44 protein in *Mycobacterium avium* subsp. *avium*
  MAP 0047c           Extracellular                                                  41,1 kDa         [Lpp-LpqN family conserved in Mycobacteriaceae]{.ul}
  **MAP 0038**        **Unknown**                                                    **48,7 kDa**     **Hypothetical protein Mb0027 in** ***Mycobacterium bovis*** **AF2122/97**
  MAP 0187            Extracellular                                                  23 kDa           Superoxide dismutase in *Mycobacterium bovis*
  **MAP 0209c**       **Extracellular**                                              **56,5 kDa**     **Protein potentially involved in peptidoglycan biosynthesis in** ***Mycobacterium avium*** **subsp.** ***avium***
  **MAP 0210c**       **Cytoplasmic-Membrane**                                       **30,7 kDa**     **Secreted antigen P36/P34 precursor in** ***Mycobacterium bovis*** **, maxima ident 60%**
  MAP 0211            Cytoplasmic                                                    46 kDa           UDP-galactopyranose mutase glf in *Mycobacterium tuberculosis*
  MAP 0297            Cytoplasmic                                                    55,23 kDa        Hypothetical protein Mb1161 *Mycobacterium bovis* AF2122/97
  MAP 0334            Unknown                                                        34,386 kDa       Oxidoreductase in *Mycobacterium bovis* AF2122/97
  MAP 0900            Cytoplasmic-Membrane                                           29,6--34 kDa     Antigen 34 kDa in *Mycobacterium tuberculosis* CDC1551
  MAP 0946c           Cytoplasmic-Membrane                                           33,5 kDa         Sigma factor in *Mycobacterium avium* 104
  MAP 1012c           Cytoplasmic                                                    37,374 kDa       Hypothetical protein TMAG_01006 in *Mycobacterium tuberculosis*
  MAP 1050c           Cytoplasmic                                                    33 kDa           Peptidyl-prolyl cis-trans isomerase, cyclophilin-type conserved in Mycobacterium
  **MAP 1272**        **Extracellular**                                              **33,4 kDa**     **NLP/P60 family protein in** ***Mycobacterium tuberculosis*** **CDC1551**
  MAP 1293            Unknown                                                        49,24 kDa        Histidinol dehydrogenase his D in *Mycobacterium tuberculosis*
  MAP 1308            Unknown (This protein may have multiple localization sites.)   46 kDa           Prolipoprotein diacylglyceryl transferase lgt in *Mycobacterium tuberculosis*
  MAP 1564c           Unknown                                                        23,01 kDa        Short chain dehydrogenase in *Mycobacterium bovis*
  MAP 1589c           Cytoplasmic                                                    21,60 KDa        Alkyl hydroperoxide reductase subunit C in *Mycobacterium tuberculosis*
  MAP 1653            Unknown                                                        16,7--20 kDa     Thiol peroxidase tpx in *Mycobacterium tuberculosis* T17
  **MAP 1693c**       **Unknown**                                                    **18,30 kDa**    **Peptidyl-prolyl cis-trans isomerase domain-containing protein conserved in Mycobacterium**
  MAP 1754c           Cytoplasmic-Membrane                                           30,84 kDa        Hypothetical protein Rv2005c in *Mycobacterium tuberculosis* H37Rv
  MAP 1889c           Cytoplasmic                                                    28 kDa           Wag31 protein in *Mycobacterium avium* 104
  MAP 1962            Cytoplasmic                                                    53,68 kDa        Glutamine synthetase glnA1 in *Mycobacterium tuberculosis*
  **MAP 2020**        **Unknown**                                                    **26,90 kDa**    **Cutinase in** ***Mycobacterium bovis*** **AF2122/97**
  MAP 2167            Extracellular                                                  17 kDa           Low molecular weight protein antigen cfp2 in *Mycobacterium tuberculosis*
  MAP 2182            Cytoplasmic-Membrane                                           16 kDa           Deazaflavin-dependent nitroreductase family protein in Mycobacterium
  **MAP 2513**        **Cytoplasmic**                                                **36,50 kDa**    **Alkanal monooxygenase alpha chain in *Mycobacterium avium* 104**
  MAP 2609            Cytoplasmic-Membrane                                           11,40 kDa        Low molecular weight T-cell antigen TB8.4 in *Mycobacterium tuberculosis*
  MAP 2676c           Cytoplasmic                                                    13,89 kDa        Hypothetical protein MAV_1246 in *Mycobacterium avium* 104
  MAP 2685            Unknown                                                        21,20 kDa        Hypothetical protein BCG_1169c in *Mycobacterium bovis* BCG str. Pasteur 1173P2
  MAP 2878c           Cytoplasmic                                                    25,43 kDa        Dihydrodipicolinate reductase in *Mycobacterium bovis* BCG str. Pasteur 1173P2
  MAP 2942c           Extracellular                                                  18,30 kDa        Soluble secreted antigen MPT53 in *Mycobacterium tuberculosis*
  MAP 2956            Cytoplasmic                                                    30,02 kDa        30S ribosomal protein S2 in *Mycobacterium tuberculosis* H37Rv
  MAP 3175c           Cytoplasmic                                                    41,38 kDa        Peptide chain release factor 2 in *Mycobacterium tuberculosis* H37Rv
  MAP 3194            Cytoplasmic                                                    30,46 kDa        Pyruvate carboxyl transferase in *Mycobacterium avium*
  MAP 3205            Cytoplasmic                                                    27 kDa           nuoE NADH dehydrogenase subunit E in *Mycobacterium avium* 104
  MAP 3206            Cytoplasmic                                                    48-49 kDa        nuoF NADH-Quinone oxidoreductase subunit F in *Mycobacterium tuberculosis*
  Mb 3341c            Unknown                                                        10,63 kDa        Equivalent to Rv3312A, len: 103 aa, from *Mycobacterium tuberculosis* strain H37Rv
  MAP 3402            Cytoplasmic                                                    33,28 kDa        Thiosulfate sulfurtransferase in *Mycobacterium*   *bovis* AF2122/97
  MAP 3457            Cytoplasmic                                                    47,61 kDa        O-acetylhomoserine sulfhydrylase metC in *Mycobacterium tuberculosis* T92
  MAP 3491            Cytoplasmic                                                    28,16 kDa        Hydrolase in *Mycobacterium tuberculosis* SUMu003
  MAP 3527            Unknown                                                        35,70 kDa        Serine protease PepA in Mycobacterium tuberculosis H37Rv
  MAP 3627            Cytoplasmic                                                    37,37 kDa        O-methyltransferase in *Mycobacterium tuberculosis* H37Rv
  MAP 3651            Cytoplasmic                                                    44 kDa           Acyl-CoA dehydrogenase fadE3 in *Mycobacterium bovis* BCG
  MAP 3692            Cytoplasmic                                                    47 kDa           fabG 3-ketoacyl-ACP reductase in *Mycobacterium tuberculosis* H37Rv
  MAP 3840            Cytoplasmic                                                    67 kDa           Heat shock protein 70, molecular chaperone DnaK in Mycobacterium
  MAP 3841            Unknown                                                        23,57 kDa        Heat shock protein GrpE in *Mycobacterium bovis* AF2122/97
  MAP 3857            Cytoplasmic                                                    18,73 kDa        Orotate phosphoribosyltransferase phosphoribosyltransferase in *Mycobacterium tuberculosis* CDC1551
  MAP 3936            Cytoplasmic                                                    57 kDa           Heat shock protein 65, GroEL in Mycobacterium sp
  MAP 4000c           Unknown                                                        12 kDa           Esat-6 like protein esxF in Mycobacterium and hypothetical protein Mb3935c in *Mycobacterium bovis*
  MAP 4143            Cytoplasmic                                                    43,77 kDa        Iron-regulated elongation factor tu in *Mycobacterium tuberculosis*
  MAP 4147            Cytoplasmic                                                    42,09 kDa        Ferredoxin reductase in *Mycobacterium tuberculosis* H37Rv
  MAP 4227c           Cytoplasmic                                                    30,14 kDa        Hypothetical protein Rv3463 in *Mycobacterium tuberculosis* H37Rv

###### 

Spot intensities for protein macroarrays.

  Antigen assayed   Mean spot intensity of proteins exposed to sera              
  ----------------- ------------------------------------------------- ---------- ---------
  MAP 0011          112                                               135        0
  MAP 0034          240                                               247        0
  **MAP 0038**      **141**                                           **860**    **0**
  MAP 0047          344                                               309        0
  MAP 0187c         184                                               0          0
  **MAP 0209c**     **367**                                           **499**    **0**
  **MAP 0210c**     **0**                                             **398**    **0**
  MAP 0211          *0*                                               *572*      *0*
  MAP 0297          117                                               225        130
  MAP 0334          108                                               167        1
  MAP 0900          *0*                                               *749*      *0*
  MAP 0946          *218*                                             *900*      *295*
  MAP 1012          280                                               0          0
  MAP 1050          268                                               275        0
  **MAP 1272**      **223**                                           **733**    **0**
  MAP 1293          585                                               481        396
  MAP 1308          163                                               894        0
  MAP 1564          259                                               344        0
  MAP 1589c         323                                               682        466
  MAP 1653          398                                               844        461
  **MAP 1693**      **226**                                           **967**    **209**
  MAP 1754          0                                                 142        27
  MAP 1889c         280                                               180        494
  MAP1962           341                                               270        354
  **MAP 2020**      **0**                                             **150**    **228**
  MAP 2167          315                                               0          0
  MAP 2182c         223                                               117        192
  **MAP 2513**      **41**                                            **164**    **291**
  MAP 2609          137                                               308        0
  MAP 2676          201                                               138        0
  MAP 2685          317                                               323        0
  MAP 2878          307                                               323        0
  MAP 2942          136                                               251        0
  MAP 2956          345                                               119        424
  MAP 3175          343                                               130        0
  MAP 3194          0                                                 100        0
  MAP 3205          0                                                 0          0
  MAP 3206          100                                               200        0
  Mb 3341           159                                               171        178
  MAP 3402          205                                               178        250
  MAP 3457          447                                               365        325
  MAP3491           286                                               454        177
  MAP 3527          528                                               414        635
  MAP 3627          207                                               265        0
  MAP 3651          1000                                              906        958
  MAP 3692c         305                                               212        0
  MAP 3840          0                                                 198        712
  MAP 3841          707                                               678        457
  MAP 3857          373                                               267        265
  MAP 3936          381                                               544        691
  MAP 4000c         134                                               242        0
  MAP4143           413                                               397        439
  MAP 4147          1000                                              556        0
  MAP 4227          138                                               101        0
  PPDA              208                                               105        256
  PPDB              346                                               531        1468
  PPA-3             131                                               609        108
  **Cocktail**      **140**                                           **1460**   **0**

Intensities were obtained using ImageQuant TL Array Version 7.0 Software, (GE Healthcare, Pittsburgh, PA). Antigens selected to evaluate as cocktail are shown in bold. PPA-3: Paratuberculosis protoplasmatic antigen (Allied Monitor, Inc. USA); PPDA and PPDB: avian- and bovine-derivative protein purified, respectively (Prionic Switzerland). Cocktail: mix of the 7 antigens shown in bold.

###### 

Reactivity of bovine sera to the panel of selected antigens from MAP.

  Antigen assayed   No. of sera with positive recognition            
  ----------------- --------------------------------------- -------- -------
  MAP 0011          0                                       5        4
  MAP 0034          5                                       5        0
  **MAP 0038**      **3**                                   **8**    **0**
  MAP 0047          3                                       4        0
  MAP 0187c         1                                       1        0
  **MAP 0209c**     **4**                                   **9**    **0**
  **MAP 0210c**     **0**                                   **8**    **0**
  MAP 0211          0                                       6        0
  MAP 0297          2                                       4        1
  MAP 0334          2                                       15       1
  MAP 0900          0                                       3        0
  MAP 0946          1                                       8        0
  MAP 1012          2                                       0        0
  MAP 1050          4                                       9        0
  **MAP 1272**      **2**                                   **8**    **0**
  MAP 1293          10                                      13       1
  MAP 1308          2                                       2        0
  MAP 1564          5                                       1        0
  MAP 1589c         2                                       9        2
  MAP 1653          10                                      20       8
  **MAP 1693**      **3**                                   **12**   **2**
  MAP 1754          0                                       5        4
  MAP 1889c         7                                       7        3
  MAP 1962          3                                       16       5
  **MAP 2020**      **0**                                   **9**    **2**
  MAP 2167          3                                       0        0
  MAP 2182c         5                                       1        2
  **MAP 2513**      **1**                                   **6**    **2**
  MAP 2609          2                                       4        0
  MAP 2676          1                                       4        0
  MAP 2685          10                                      2        0
  MAP 2878          10                                      2        0
  MAP 2942          2                                       7        0
  MAP 2956          1                                       1        1
  MAP 3175          4                                       4        4
  MAP 3194          0                                       1        0
  MAP 3205          0                                       0        0
  MAP 3206          1                                       5        0
  Mb 3341           4                                       6        3
  MAP 3402          2                                       20       1
  MAP 3457          10                                      8        4
  MAP 3491          7                                       7        1
  MAP 3527          6                                       25       8
  MAP 3627          3                                       4        0
  MAP 3651          10                                      14       8
  MAP 3692c         5                                       8        0
  MAP 3840          0                                       3        3
  MAP 3841          10                                      14       1
  MAP 3857          10                                      4        4
  MAP 3936          5                                       8        4
  MAP 4000c         3                                       5        0
  MAP 4143          8                                       16       7
  MAP 4147          1                                       3        0
  MAP 4227          1                                       1        1
  PPDA              6                                       1        4
  PPDB              4                                       16       3
  PPA-3             1                                       18       2
  **Cocktail**      **2**                                   **14**   **0**

20 uL of antigens were applied to a nitrocellulose membrane (Amersham Hybond-ECL, GE Healthcare Life Sciences, UK) at a concentration of 100 ug/mL, using a semiautomatic aerolizer (Camag Scientific Inc., Wilmington, Delaware). Membranes were evaluated by immunoblotting using sera from healthy and infected animals. Numbers of sera with antibody response are indicated. Samples with intensities values higher than the media obtained with the control (PBS) were considered positive. Antigens selected to evaluate as cocktail are shown in bold. PPA-3: Paratuberculosis protoplasmatic antigen (Allied Monitor, Inc. USA); PPDA and PPDB: avian- and bovine-derivative protein purified (Prionic Switzerland ); Cocktail: Mix of the 7 antigens shown in bold.

[^1]: Academic Editor: Jesse M. Hostetter
